These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15114390)

  • 1. [Modern diagnosis and treatment of heart failure].
    Gullestad L; Madsen S
    Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1107-10. PubMed ID: 15114390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of chronic heart failure].
    Watzinger N; Fruhwald FM; Klein W
    Wien Med Wochenschr; 1998; 148(5):128-30, 132-3. PubMed ID: 9654699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyspnea and normal systolic function].
    Hasenfuss G; Hermann HP; Pieske B
    Herz; 2004 Sep; 29(6):602-8. PubMed ID: 15912435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic heart failure.
    Frigerio M; Aguggini G
    Ital Heart J; 2004 Jun; 5 Suppl 6():48S-54S. PubMed ID: 15185915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
    Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
    Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.
    Voors AA; van Veldhuisen DJ
    Minerva Cardioangiol; 2005 Aug; 53(4):233-9. PubMed ID: 16177668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues in heart failure: overview of an emerging need.
    Kirkpatrick JN; Kim AY
    Perspect Biol Med; 2006; 49(1):1-9. PubMed ID: 16489272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the management of heart failure.
    Young R; Worthley LI
    Crit Care Resusc; 2004 Mar; 6(1):31-53. PubMed ID: 16563104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic heart failure--optimising care in general practice.
    Piterman L; Zimmet H; Krum H; Tonkin A; Yallop J
    Aust Fam Physician; 2005 Jul; 34(7):547-53. PubMed ID: 15999165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of congestive heart failure].
    Aarønaes M; Atar D; Bonarjee V; Gundersen T; Løchen ML; Mo R; Myhre ES; Omland T; Rønnevik PK; Vegsundvåg J; Westheim A
    Tidsskr Nor Laegeforen; 2007 Jan; 127(2):174-7. PubMed ID: 17237864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The less familiar side of heart failure: symptomatic diastolic dysfunction.
    Morris SA; Van Swol M; Udani B
    J Fam Pract; 2005 Jun; 54(6):501-11. PubMed ID: 15939000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.